MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$568,791
EPS
-$0.03
Unit: Dollar

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
General and administrative
270,153 383,729 341,203 414,676*
Revenues
-0 --
Research and development
20,454 14,430 13,214 93,317.75*
Stock-based compensation
277,226 250,189 231,933 1,849,987.25*
Total operating expenses
567,833 648,348 586,350 2,357,981*
Interest expense, net
958 1,070 909 960*
Net loss
-568,791 -649,418 -587,259 -2,358,941
Basic EPS
-0.03 -0.034 -0.03 -0.131
Diluted EPS
-0.03 -0.034 -0.03 -0.131
Basic Average Shares
18,579,776 18,326,587 18,522,295 17,988,233
Diluted Average Shares
18,579,776 18,326,587 18,522,295 17,988,233
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$568,791 (11.72%↑ Y/Y)Total operatingexpenses$567,833 (-11.74%↓ Y/Y)Interest expense, net$958 (-0.21%↓ Y/Y)Stock-based compensation$277,226 (-6.42%↓ Y/Y)General andadministrative$270,153 (10.67%↑ Y/Y)Research and development$20,454 (-80.14%↓ Y/Y)

RetinalGenix Technologies Inc. (RTGN)

RetinalGenix Technologies Inc. (RTGN)